Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Chronic Neuropathic Pain.

NCT00141362 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00141362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00141362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Chronic Neuropathic Pain.
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2001
Completion date
August 31, 2005
Enrollment
325
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pain